136 related articles for article (PubMed ID: 8095797)
1. Uses of polymerase chain reaction in leukemia: detection of minimal residual disease and identification of novel genetic mutations.
Lee MS; Stass SA
Cancer Treat Res; 1993; 64():35-44. PubMed ID: 8095797
[No Abstract] [Full Text] [Related]
2. Diagnosis of minimal residual disease in bone marrow transplant patients.
Gehly GB
Clin Lab Med; 1992 Mar; 12(1):129-51. PubMed ID: 1563238
[No Abstract] [Full Text] [Related]
3. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
4. Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia.
Pignon JM; Henni T; Amselem S; Vidaud M; Duquesnoy P; Vernant JP; Kuentz M; Cordonnier C; Rochant H; Goossens M
Leukemia; 1990 Feb; 4(2):83-6. PubMed ID: 2406520
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the third Workshop of the Molecular Biology/BMT study group.
Hughes TP; Ambrosetti A; Barbu V; Bartram C; Battista R; Biondi A; Chiamenti A; Cimino G; Ernst P; Frassoni F
Leukemia; 1991 Jun; 5(6):448-51. PubMed ID: 2056768
[TBL] [Abstract][Full Text] [Related]
6. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
Sawyers CL; Timson L; Kawasaki ES; Clark SS; Witte ON; Champlin R
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384
[TBL] [Abstract][Full Text] [Related]
7. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
Okamoto R; Harano H; Matsuzaki M; Motomura S; Maruta A; Kodama F; Mohri H; Okubo T
Am J Clin Pathol; 1995 Nov; 104(5):510-6. PubMed ID: 7572810
[TBL] [Abstract][Full Text] [Related]
8. [Detection of minimal residual leukemia after bone marrow transplantation in patients with chronic myeloid leukemia using the polymerase chain reaction].
Matsue K; Nakamura K; Mizutani S
Rinsho Ketsueki; 1990 May; 31(5):603-8. PubMed ID: 2395211
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction.
Lion T; Izraeli S; Henn T; Gaiger A; Mor W; Gadner H
Leukemia; 1992 Jun; 6(6):495-9. PubMed ID: 1602787
[TBL] [Abstract][Full Text] [Related]
10. Chronic Myelogenous Leukemia Presenting as a Secondary Malignancy After BCR-ABL1-negative B-lymphoblastic Leukemia/Lymphoma in a Pediatric Patient.
Popa G; Blag C; Olteanu H
Pediatr Dev Pathol; 2017; 20(1):58-62. PubMed ID: 28276292
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization.
Amiel A; Yarkoni S; Slavin S; Or R; Lorberboum-Galski H; Fejgin M; Nagler A
Cancer Genet Cytogenet; 1994 Aug; 76(1):59-64. PubMed ID: 8076354
[TBL] [Abstract][Full Text] [Related]
12. [Leukemias and malignant lymphomas in children].
Schmiegelow K
Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
[No Abstract] [Full Text] [Related]
13. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
[TBL] [Abstract][Full Text] [Related]
14. Adult leukaemia in 1995: new directions.
Scheinberg DA
Lancet; 1995 Aug; 346(8973):455-6. PubMed ID: 7637474
[No Abstract] [Full Text] [Related]
15. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.
Maurer J; Janssen JW; Thiel E; van Denderen J; Ludwig WD; Aydemir U; Heinze B; Fonatsch C; Harbott J; Reiter A
Lancet; 1991 May; 337(8749):1055-8. PubMed ID: 1673492
[TBL] [Abstract][Full Text] [Related]
16. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.
Ni H; Nitta M; Komatsu H; Kojima S; Suzuki S; Harada S; Tsuboi K; Banno S; Wakita A; Yazaki M; Ren L; Kato T; Ueda R
Cancer Lett; 1998 Feb; 124(2):173-80. PubMed ID: 9500207
[TBL] [Abstract][Full Text] [Related]
17. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation.
Gabert J; Thuret I; Lafage M; Carcassonne Y; Maraninchi D; Mannoni P
Lancet; 1989 Nov; 2(8672):1125-8. PubMed ID: 2572849
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of minimal residual disease in leukemia, advantages and pitfalls.
Cazzaniga G; Gaipa G; Rossi V; Biondi A
Ann Med; 2006; 38(7):512-21. PubMed ID: 17101542
[TBL] [Abstract][Full Text] [Related]
19. Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization.
Nagler A; Slavin S; Yarkoni S; Fejgin M; Amiel A
Cancer Genet Cytogenet; 1994 Apr; 73(2):130-3. PubMed ID: 8174087
[TBL] [Abstract][Full Text] [Related]
20. The detection and significance of minimal residual disease in chronic myeloid leukemia.
Radich JP
Medicina (B Aires); 2000; 60 Suppl 2():66-70. PubMed ID: 11188935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
